In peripheral-blood proteomes, XRRA1 was quantitatively reduced in chronic myeloid leukemia yet associated with a favorable prognosis and with networks enriched for RNA regulation, apoptosis, and DNA-repair biology. Here, XRRA1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.